Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada · Delayed Price · Currency is CAD 1.750
+0.050 (2.94%)
Nov 13, 2026, 11:20 AM EST
TSXV:EBM Market Cap
TSXV:EBM has a market cap or net worth of CAD 120.55 million as of November 13, 2026. It is the 26,132nd most valuable company in the world and the 684th biggest in Canada. Its market cap has increased by 186.89% in one year.
Market Cap
120.55M
Enterprise Value
120.61M
Revenue
812.12K
Global Rank
Country Rank
#684 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since September 19, 2014, TSXV:EBM's market cap has increased from 26.94M to 120.55M, an increase of 347.44%. That is a compound annual growth rate of 13.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 120.55M | 116.05% |
| Dec 31, 2025 | 55.80M | 50.00% |
| Dec 31, 2024 | 37.20M | -1.82% |
| Dec 6, 2023 | 37.89M | -45.00% |
| Dec 30, 2022 | 68.89M | -28.57% |
| Dec 30, 2021 | 96.44M | -30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 325.51M |
| Satellos Bioscience | 203.04M |
| Helix BioPharma | 64.92M |
| Thiogenesis Therapeutics | 45.49M |
| NurExone Biologic | 44.82M |
| Sharp Therapeutics | 43.26M |
| BriaCell Therapeutics | 42.79M |
| Microbix Biosystems | 40.41M |